Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$15.9K Hold
140
0.01% 204
2024
Q1
$19.4K Hold
140
0.02% 197
2023
Q4
$17.4K Hold
140
0.02% 200
2023
Q3
$13.1K Hold
140
0.01% 224
2023
Q2
$18K Hold
140
0.02% 212
2023
Q1
$16.3K Hold
140
0.02% 221
2022
Q4
$15.9K Hold
140
0.02% 211
2022
Q3
$11K Hold
140
0.01% 256
2022
Q2
$10K Hold
140
0.01% 269
2022
Q1
$18K Hold
140
0.02% 244
2021
Q4
$19K Hold
140
0.02% 251
2021
Q3
$19K Hold
140
0.02% 257
2021
Q2
$15K Buy
+140
New +$13.4K 0.01% 269

Other funds holding DXCM

EMFO LLC's DXCM Position: Q2 2024 in Review

EMFO LLC held its DexCom (DXCM) position steady in Q2 2024 at 140 shares worth $15.9K. The position accounts for 0.01% of the portfolio, ranked #204.

EMFO LLC first reported a position in DXCM in Q2 2021 and has held it in 13 quarters since. The position peaked at $19.4K in Q1 2024. 999 funds tracked by Wall St. Rank hold DXCM as of Q2 2024.

  • EMFO LLC held 140 shares of DexCom worth $15.9K as of Q2 2024.
  • EMFO LLC left its DexCom share count unchanged in Q2 2024.
  • DexCom made up 0.01% of EMFO LLC's portfolio in Q2 2024, its #204 holding.
  • EMFO LLC first reported a position in DexCom in Q2 2021 and has held it in 13 quarters since.
  • EMFO LLC's DexCom position peaked at $19.4K in Q1 2024.
  • 999 funds tracked by Wall St. Rank held DexCom as of Q2 2024.

Based on EMFO LLC's 13F filing for Q2 2024, filed 26 Jul 2024.